Condensed N-heterocyclic compounds and their use as CRF receptor antagonists

Details for Australian Patent Application No. 2004232551 (hide)

International Classifications

Event Publications

20 October 2005 PCT application entered the National Phase

PCT publication WO2004/094420 Priority application(s): WO2004/094420

11 September 2008 Application Accepted

Published as AU-B-2004232551

30 October 2008 Assignment before Grant

Neurocrine Biosciences Inc; SB Pharmco Puerto Rico Inc The application has been assigned to Neurocrine Biosciences Inc; SmithKline Beecham (Cork) Limited

25 February 2010 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 13 Oct 2008. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

17 June 2010 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 13 Oct 2008

17 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.